Status:
WITHDRAWN
Buprenorphine Induction for Fentanyl Dependent Opioid Users
Lead Sponsor:
Milton S. Hershey Medical Center
Conditions:
Opioid Dependence Fentanyl
Eligibility:
All Genders
18-99 years
Phase:
EARLY_PHASE1
Brief Summary
The overall goal of this pilot study is to characterize illicit fentanyl and combination fentanyl and opioid dependence explicitly, by assessing physiologic barriers to effective buprenorphine inducti...
Detailed Description
Illicit synthetic fentanyl is found in increasing proportions of illicit drug samples, and negatively influences how buprenorphine is used on the street to help with subjective withdrawal symptoms. In...
Eligibility Criteria
Inclusion
- 18 years of age or older
- Diagnosis of opioid use disorder (OUD) as determined through routine clinical care
- Positive for fentanyl on point of care urine drug screen
- Ability to read, write, and comprehend English
- Patients willing to start buprenorphine at the onset of treatment (e.g., clinical intake)
- Patients who need to initiate a buprenorphine induction at home must have an operating smartphone or tablet device with video capability.
Exclusion
- Initiating maintenance treatment that does not include MAT or switching to a maintenance treatment that does not include MAT (i.e.: detoxification and counseling treatment only without MAT, or planning to enter methadone treatment).
- Judged by the evaluating physician or allied clinician to need a higher level of care (i.e.: residential or inpatient treatment)
- Pregnant
- Patients desiring to start methadone or naltrexone at the onset of treatment (e.g., clinical intake)
- Patients who are unable to stay in the clinic for the induction period.
Key Trial Info
Start Date :
May 9 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 22 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04794790
Start Date
May 9 2022
End Date
June 22 2024
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Pennsylvania Psychiatric Institute
Harrisburg, Pennsylvania, United States, 17110